Member Info for wahlberg

Risk - no deal Reward - multiple license deals, blockbuster revenues, £500m+ business Pretty easy stuff to comprehend

How else can you speak about the future other than hypothetically? "Nigel said it was impossible to say where the company would be in a few years, only that he was confident it will be making vast sums of money" Entrepreneurial. Proven track record. Top 100 within Bio/Pharma. Brilliant stuff

Of course it's my opinion. This is a forum for people to post opinions. I don't need someone to write "IMO" after everything, lol In NT's opinion, n4 will soon be making vast sums of money. I like the sound of that.

I'm looking to add, silly cheap

csn, according to "Dave" we aren't allowed to speculate about future potential. Everything has to be guaranteed. There's no consideration of risk vs reward allowed either. lol

What "Dave"s investment criteria is * Ground-breaking product * Fully patented * All deals in place * $bn markets * Fully funded * No competitors * No risk of alternatives * No risk of obsolescence * Future success guaranteed * Future ahare price appreciation guaranteed * 0 risk Please give us some tips haha

I don't need to 'get back to you' I understand foresight, potential and risk. The risk vs reward here is exceptional. And that's as simple as it gets. And it's not my use of the word 'imagine', it's NT, a guy who has done it all before.

""I imagine we'll end up with close to 10, or even 20, real quality new products as a result of this deal."" 10 or 20 products Multi-billion £ markets Annual royalties with very low overheads Proof of concept stage and license out Breathtaking potential

Actually, I think you've proven that given you were unable to find the article with a search engine and a direct quote Funny

Links seem to work in desktop view

Haha, link removed Mate, you'd think that with a direct quote from the article and the internet, any numpty could find it

Cocrys, Nuvac, Nuvec Broad range of therapeutic areas and multiple opportunities for revenue potential. There's a lot of Pharma companies, drugs and vaccines that may benefit from these platforms. Now, do I wait to see if n4 get a deal and *then* try to buy shares at a significantly higher price with lower risk but reduced upside, or do I buy at an incredibly low price with higher risk but significant upside. I choose the latter - simple

Why do I need you to verify it?

Interested to see it? What, so you can manipulate it and twist things into a negative, right?

"I've got a firm view that it's not the percentage that matters, it's the final result. I could end up owning 100% of nothing, or a good percentage of something that's got the potential to become £500 million or more. To me it's a no brainer." Word for word. And when asked on twitter, NT said to "think bigger"

newspaper*

"If N4 do not get a deal" I knew this would be your default reply. If If If...... Pathetic. With multiple delivery platforms across several drugs and vaccines, I'm very confident they will. And so is NT.

Shire currently £43.5bn market capitalisation So I'll settle for £100m+ for n4 A licensing deal on the viagra product alone and we're on our way there.

Plucked it right from an interview! Nigel said the deal made sense. "I've got a firm view that it's not the percentage that matters, it's the final result. I could end up owning 100% of nothing, or a good percentage of something that's got the potential to become £500 million or more. To me it's a no brainer." And reiterated again by NT elsewhere too. Great stuff.

"N4 at this present time has nothing but 2 delivery systems that it will try to find a partner for." Did you say that about OXP when they were at the same stage? Now a £60m+ company. N4 aiming for £500m+ company Huge upside